Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000490168 | SCV000576717 | pathogenic | not provided | 2017-04-20 | criteria provided, single submitter | clinical testing | The A1186T variant in the SMARCA4 gene has not been reported previously as a germline pathogenic variant, nor as a benign variant, to our knowledge. The A1186T variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The A1186T variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs within the HELICc domain at a position that is conserved across species (Witkowski et al., 2014). In silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret A1186T as a pathogenic variant |